Citation Impact
Citing Papers
Environmental Contamination Due to Methicillin-Resistant Staphylococcus aureus: Possible Infection Control Implications
1997
Immunomodulatory Function of Interleukin 28B During Primary Infection With Cytomegalovirus
2014 StandoutNobel
Eradication strategy for persistent methicillin-resistant Staphylococcus aureus infection in individuals with cystic fibrosis—the PMEP trial: study protocol for a randomized controlled trial
2014
Infective Endocarditis
2005 Standout
Prediction of Pulmonary Complications and Long‐Term Survival in Systemic Sclerosis
2014
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE
2013 Standout
Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study
2021 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
A Systematic Review of Factors Associated with Health-Related Quality of Life in Adolescents and Adults with Cystic Fibrosis
2015
Antibiotic Management of Lung Infections in Cystic Fibrosis. I. The Microbiome, Methicillin-Resistant Staphylococcus aureus , Gram-Negative Bacteria, and Multiple Infections
2014
Clinical impact of antibiotic-resistant Gram-positive pathogens
2009
Engineering precision nanoparticles for drug delivery
2020 Standout
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Year-to-year changes in lung function in individuals with cystic fibrosis
2010
Interventions for the eradication of methicillin-resistantStaphylococcus aureus(MRSA) in people with cystic fibrosis
2013
Failure to Recover to Baseline Pulmonary Function after Cystic Fibrosis Pulmonary Exacerbation
2010
Management of comorbidities in older patients with cystic fibrosis
2013
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR
2015 Standout
Pulmonary veno-occlusive disease
2016
Connective Tissue Disease-Associated Interstitial Lung Disease
2010
Development and evaluation of a palliative care curriculum for cystic fibrosis healthcare providers
2015
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
2010 Standout
Infection Control and Cost Control in the Era of Managed Care
2002
Cystic fibrosis
2016 Standout
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
The role of autophagy in neurodegenerative disease
2013 Standout
Patient Understanding, Detection, and Experience of COPD Exacerbations
2006
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features
2015 Standout
Treatment with lithium carbonate does not improve disease progression in two different strains of SOD1 mutant mice
2009
Community-associated meticillin-resistant Staphylococcus aureus
2010
Ambrisentan response in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) – A subgroup analysis of the ARIES-E clinical trial
2016
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
2011 Standout
Pulmonary Hypertension in Chronic Lung Diseases
2013
Systemic sclerosis
2017 Standout
Infection Control — A Problem for Patient Safety
2003 Standout
Amyotrophic lateral sclerosis
2011 Standout
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
2011 Standout
Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis
2015
The Influence of Inadequate Antimicrobial Treatment of Bloodstream Infections on Patient Outcomes in the ICU Setting
2000 Standout
A Review of the Research Literature on Evidence-Based Healthcare Design
2008 Standout
Severe Sepsis and Septic Shock
2013 Standout
Patient segregation and aggressive antibiotic eradication therapy can control methicillin-resistant Staphylococcus aureus at large cystic fibrosis centres
2010
The management of motor neurone disease
2003
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
2008 Standout
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Amyotrophic lateral sclerosis: A 40-year personal perspective
2009
The mental and physical health outcomes of green exercise
2005 Standout
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
2011 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Effect of exposure to natural environment on health inequalities: an observational population study
2008 Standout
One-year Treatment of Morpholino Antisense Oligomer Improves Skeletal and Cardiac Muscle Functions in Dystrophic mdx Mice
2010
Physical environmental stimuli that turn healthcare facilities into healing environments through psychologically mediated effects: systematic review
2006 Standout
Sepsis and septic shock
2018 Standout
Mortality in COPD: role of comorbidities
2006
Current approach to connective tissue disease-associated interstitial lung disease
2014
Idiopathic pulmonary fibrosis
2017 Standout
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis
2014
Patient considerations and drug selection in the treatment of idiopathic pulmonary fibrosis
2016
Adult Cystic Fibrosis
2007
Association Between Respiratory Tract Methicillin-Resistant S<emph type="ital">taphylococcus aureus</emph> and Survival in Cystic Fibrosis
2010
Lung function impairment, COPD hospitalisations and subsequent mortality
2011
Vancomycin-Resistant Enterococcal Infections
2000 Standout
Knowledge Modeling Tool for Evidence-Based Design
2010
Natural history of idiopathic pulmonary fibrosis
2015
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
Comorbidity and Mortality in COPD-Related Hospitalizations in the United States, 1979 to 2001
2005 Standout
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
2015 Standout
Factors affecting survival of hospitalised patients with COPD
2005
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Major lung complications of systemic sclerosis
2018
State-of-the-Art Monitoring of Cytomegalovirus-Specific Cell-Mediated Immunity After Organ Transplant: A Primer for the Clinician
2012
Update on Key Emerging Challenges in Cystic Fibrosis
2014 Standout
Impact of the More-Potent Antibiotics Quinupristin-Dalfopristin and Linezolid on Outcome Measure of Patients with Vancomycin-Resistant Enterococcus Bacteremia
2007
Vancomycin-resistant enterococci: 15 years and counting
2003
Lipid Nanoparticle-Delivered Chemically Modified mRNA Restores Chloride Secretion in Cystic Fibrosis
2018
Comparison of 8 vs 15 Days of Antibiotic Therapy for Ventilator-Associated Pneumonia in Adults
2003 Standout
Adherence with tobramycin inhaled solution and health care utilization
2011
Diagnosis and Treatment of Connective Tissue Disease-Associated Interstitial Lung Disease
2013
Interstitial lung disease in connective tissue disorders
2012
Cystic fibrosis
2009
Global burden of COPD: risk factors, prevalence, and future trends
2007 Standout
Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study
2004 Standout
COPD exacerbations {middle dot} 1: Epidemiology
2006
Antibiotic and Anti-Inflammatory Therapies for Cystic Fibrosis
2013
Differences in COPD Exacerbation Risk Between Women and Men
2019
Treatment of lung infection in patients with cystic fibrosis: Current and future strategies
2012
Polyfunctional T-Cell Signatures to Predict Protection from Cytomegalovirus after Lung Transplantation
2015
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Gut Microbiota in Health and Disease
2010 Standout
Prevalence of Community-Associated Methicillin-Resistant Staphylococcus aureus in Patients with Cystic Fibrosis
2009
Clinical iron deficiency disturbs normal human responses to hypoxia
2016 StandoutNobel
Healing environment: A review of the impact of physical environmental factors on users
2012 Standout
The Business Case for Better Buildings
2004 Standout
Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis
2015
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
2019 Standout
Antibiotic Resistance in the Intensive Care Unit
2001
Antibiotic Management of Methicillin-Resistant Staphylococcus aureus–Associated Acute Pulmonary Exacerbations in Cystic Fibrosis
2015
Progress and prospects of early detection in lung cancer
2017
Essay: Evidence-based health-care architecture
2006 Standout
Immune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease
2019
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization
2020 StandoutNobel
Molecular Origin of Blood‐Based Infrared Spectroscopic Fingerprints**
2021 StandoutNobel
Idiopathic Pulmonary Fibrosis
2018 Standout
Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF)
2017
Multicenter Study of High-Dose Daptomycin for Treatment of Enterococcal Infections
2013
Works of Noah Lechtzin being referenced
Differential CMV-Specific CD8+ Effector T Cell Responses in the Lung Allograft Predominate over the Blood during Human Primary Infection
2008
Vancomycin‐Resistant and Vancomycin‐Susceptible Enterococcal Bacteremia: Comparison of Clinical Features and Outcomes
1998
Systemic sclerosis–related pulmonary hypertension associated with interstitial lung disease: Impact of pulmonary arterial hypertension therapies
2011
In-Hospital Mortality Following Acute Exacerbations of Chronic Obstructive Pulmonary Disease
2003
The Relationship Between Age and Process of Care and Patient Tolerance of Bronchoscopy
2003
Use of noninvasive ventilation in patients with amyotrophic lateral sclerosis
2004
Ascertainment of collagen vascular disease in patients presenting with interstitial lung disease
2009
Current treatment of adult Duchenne muscular dystrophy
2006
Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertension
2011
Primary Cytomegalovirus Phosphoprotein 65–Specific CD8+ T-Cell Responses and T-bet Levels Predict Immune Control During Early Chronic Infection in Lung Transplant Recipients
2011
Distraction Therapy With Nature Sights and Sounds Reduces Pain During Flexible Bronchoscopya
2003
Outcomes of Adults with Cystic Fibrosis Infected with Antibiotic-Resistant <i>Pseudomonas aeruginosa</i>
2005
Incidence and Risk Factors for Multiple Antibiotic-Resistant Pseudomonas aeruginosa in Cystic Fibrosis
2007
Hemodynamic Predictors of Survival in Scleroderma-related Pulmonary Arterial Hypertension
2010
Pain Is a Common Problem Affecting Clinical Outcomes in Adults With Cystic Fibrosis
2011
Persistent Methicillin-resistant Staphylococcus aureus and Rate of FEV 1 Decline in Cystic Fibrosis
2008
Spirometry in the Supine Position Improves the Detection of Diaphragmatic Weakness in Patients With Amyotrophic Lateral Sclerosis
2002
Early use of non‐invasive ventilation prolongs survival in subjects with ALS
2007
An Observational Study of Outcomes and Tolerances in Patients with Cystic Fibrosis Initiated on Lumacaftor/Ivacaftor
2017
Patient Satisfaction with Bronchoscopy
2002
Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension
2015
Thalidomide for the Treatment of Cough in Idiopathic Pulmonary Fibrosis
2012